Adam D Morris Selected Research

Glomerulonephritis

1/2023	A Meta-Analysis and Cohort Study of Histopathologic and Clinical Outcomes in ANCA-Negative versus -Positive Vasculitis.
4/2022	Automated Computational Detection of Disease Activity in ANCA-Associated Glomerulonephritis Using Raman Spectroscopy: A Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam D Morris Research Topics

Disease

4	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2023 - 01/2021
3	Vasculitis (Vasculitides) 01/2023 - 01/2020
2	Glomerulonephritis 01/2023 - 04/2022
1	COVID-19 11/2021
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Hemorrhagic Fever with Renal Syndrome (HFRS) 01/2018

Drug/Important Bio-Agent (IBA)

6	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2023 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2023
1	Rituximab (Mabthera)FDA Link 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2020
1	2,2',3,3',4,4',5,5',6-nonabromodiphenyl etherIBA 01/2018
1	Flame Retardants (Fire Retardants)IBA 01/2018
1	Halogenated Diphenyl EthersIBA 01/2018
1	2,2',3,3',4,4',5,6,6'-nonabromodiphenyl etherIBA 01/2018

Therapy/Procedure

1	Therapeutics 01/2023
1	Remission Induction 01/2023